Early α-synuclein pathology induces disease-associated microglia and non-cell-autonomous alteration of midbrain dopamine neurons
Parkinson’s disease (PD) is characterised by alpha-synuclein (α-syn) aggregation, degeneration of midbrain dopamine (mDA) neurons, and neuroinflammation. Here, we investigated the ventral midbrain of mice heterozygous for an aggregation-prone mutated form of human α-syn(3K-hα-syn) expressed via the Thy1 promoter. Immunohistochemical analysis revealed that 3K-hα-syn accumulated predominantly in non-dopaminergic neurons of the ventral midbrain, most notably within the red nucleus, while neighbouring mDA neurons showed no detectable transgene expression or phosphorylated α-syn. Despite this, robust microgliosis was observed broadly in the ventral midbrain. Single-nucleus RNA sequencing of mDA neurons demonstrated preserved mDA neuron subtype architecture but selective induction of cholesterol biosynthesis pathways together with downregulation of synaptic gene programmes. In parallel, single-cell RNA sequencing of CD45 + immune cells from the ventral midbrain revealed a transition towards a disease-associated microglial (DAM) state characterised by upregulation of Apoe, Lgals3, Fabp5 , and inflammation-associated pathways. Histological analysis showed that Galectin-3-positive DAM accumulated over time in regions with pronounced levels of phosphorylated α-syn. Finally, pharmacological depletion of microglia using the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX3397 selectively worsened beam-traversal performance in female 3K het mice, supporting a sex-dependent protective contribution of microglia. Together, these findings demonstrate pathological α-syn accumulation coinciding with widespread microglial activation and suggest that microglia can exert context- and sex-dependent beneficial effects during early stages of 3K-hα-syn-driven neuropathology.
Authors
- Linda Gillberg
- Thomas Perlmann (ORCID: https://orcid.org/0000-0003-4821-8036)
- Per Svenningsson (ORCID: https://orcid.org/0000-0001-6727-3802)
- Silke Nuber (ORCID: https://orcid.org/0000-0002-2124-6865)
- Niclas Branzell (ORCID: https://orcid.org/0009-0009-3472-6903)
- Laura Lahti (ORCID: https://orcid.org/0000-0003-2929-1975)
- Dennis Selkoe
- Isabel Hemming
- Behzad Yaghmaeian-Salmani
Institutions
- Brigham and Women's Hospital (US)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11539990/v1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- preprint